1. Tanaka Y, Kuwana M, Fujii T, Kameda H, Muro Y, Fujio K, Itoh Y, Yasuoka H, Fukaya S, Ashihara K, Hirano D, Ohmura K, Tabuchi Y, Hasegawa H, Matsumiya R, Shirai Y, Ogura T, Tsuchida Y, Ogawa-Momohara M, Narazaki H, Inoue Y, Miyagawa I, Nakano K, Hirata S, Mori M. 2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases. Mod Rheumatol. 2020, 31(1), 29-33, doi: 10.1080/14397595.2019.1709944.
2. Yamada S, Nagafuchi Y, Kono M, Hatano H, Tateishi S, Harada H, Sumitomo S, Kubo K, Shoda H, Kanda H, Fujio K. High incidence of malignancy in SAPHO syndrome. Clin Exp Rheumatol. 2020, 38(4):805-806
3. Hanata N, Shoda H, Hatano H, Nagafuchi Y, Komai T, Okamura T, Suzuki A, Gunarta IK, Yoshioka K, Yamamoto K, Fujio K. Peptidylarginine Deiminase 4 Promotes the Renal Infiltration of Neutrophils and Exacerbates the TLR7 Agonist-Induced Lupus Mice. Front Immunol. 2020, 11, 1095, doi: 10.3389/fimmu.2020.01095.
4. Furer V, Kishimoto M, Tsuji S, Taniguchi Y, Ishihara Y, Tomita T, Helliwell PS, Elkayam O. The Diagnosis and Treatment of Adult Patients with SAPHO Syndrome: Controversies Revealed in a Multidisciplinary International Survey of Physicians. Rheumatology and therapy. 2020, 7(4), 883-891, doi: 10.1007/s40744-020-00235-2.
5. Kobayashi S, Nagafuchi Y, Okubo M, Sugimori Y, Shirai H, Hatano H, Junko M, Yanaoka H, Takeshima Y, Ota M, Iwasaki Y, Sumitomo S, Okamura T, Yamamoto K, Shoda H, Fujio K. Integrated bulk and single-cell RNA-sequencing identified disease-relevant monocytes and a gene network module underlying systemic sclerosis. J Autoimmun. 2020, 116, 102547, doi: 10.1016/j.jaut.2020.102547.
6. Shimizu T, Nagafuchi Y, Harada H, Tsuchida Y, Tsuchiya H, Hanata N, Tateishi S, Kanda H, Sumitomo S, Shoda H, Yamamoto K, Fujio K. Decreased peripheral blood memory B cells are associated with the presence of interstitial lung disease in rheumatoid arthritis: a case-control study. Mod Rheumatol. 2021, 37(1), 127-132, doi: 10.1080/14397595.2020.1719596.
7. 冨田哲也, 辻成佳, 玉城雅史,脊椎関節炎の診断,炎症と免疫, 2020, 28(2), 42-47.
8. 冨田哲也, 辻成佳, 玉城雅史, Filgotinibの強直性脊椎炎に対する効果,リウマチ科, 2020, 63(4), 443-448.
9. 冨田哲也, 治療法の再整理とアップデートのために 専門家による私の治療 強直性脊椎炎, WEB医事新報, 5013, 53-54.
10. 多田久里守, 萩森恒平, 許斐綾子, 中條航, 冨田哲也, 総説 体軸性脊椎関節炎に対するイキセキズマブの薬理学的特性ならびに有効性・安全性,新薬と臨牀, 69(9), 1046-1065.